Table of Content

1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
1.1 Product Overview and Scope of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
1.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dominant Optic Atrophy
1.2.3 Recessive Optic Atrophy
1.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
1.3.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Estimates and Forecasts
1.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2016-2027
1.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2016-2027
1.4.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competition by Manufacturers
2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Sites, Area Served, Product Type
2.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation and Trends
2.5.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue
2.5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario by Region
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.3.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.3.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.4.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.4.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Region
3.5.1 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
3.5.2 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.6.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.6.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.7.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.7.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Analysis by Type
4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2016-2021)
4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2016-2021)
4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2016-2021)

5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Analysis by Application
5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2016-2021)
5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2016-2021)
5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Alkeus Pharmaceuticals
6.1.1 Alkeus Pharmaceuticals Corporation Information
6.1.2 Alkeus Pharmaceuticals Description and Business Overview
6.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Alkeus Pharmaceuticals Product Portfolio
6.1.5 Alkeus Pharmaceuticals Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Biovista
6.3.1 Biovista Corporation Information
6.3.2 Biovista Description and Business Overview
6.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biovista Product Portfolio
6.3.5 Biovista Recent Developments/Updates
6.4 Editas Medicine
6.4.1 Editas Medicine Corporation Information
6.4.2 Editas Medicine Description and Business Overview
6.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Editas Medicine Product Portfolio
6.4.5 Editas Medicine Recent Developments/Updates
6.5 GenSight Biologics
6.5.1 GenSight Biologics Corporation Information
6.5.2 GenSight Biologics Description and Business Overview
6.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GenSight Biologics Product Portfolio
6.5.5 GenSight Biologics Recent Developments/Updates
6.6 Ixchel Pharma
6.6.1 Ixchel Pharma Corporation Information
6.6.2 Ixchel Pharma Description and Business Overview
6.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ixchel Pharma Product Portfolio
6.6.5 Ixchel Pharma Recent Developments/Updates
6.7 Khondrion
6.6.1 Khondrion Corporation Information
6.6.2 Khondrion Description and Business Overview
6.6.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Khondrion Product Portfolio
6.7.5 Khondrion Recent Developments/Updates
6.8 Mitotech
6.8.1 Mitotech Corporation Information
6.8.2 Mitotech Description and Business Overview
6.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mitotech Product Portfolio
6.8.5 Mitotech Recent Developments/Updates
6.9 ProQR Therapeutics
6.9.1 ProQR Therapeutics Corporation Information
6.9.2 ProQR Therapeutics Description and Business Overview
6.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ProQR Therapeutics Product Portfolio
6.9.5 ProQR Therapeutics Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Sanofi Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Spark Therapeutics
6.11.1 Spark Therapeutics Corporation Information
6.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Spark Therapeutics Product Portfolio
6.11.5 Spark Therapeutics Recent Developments/Updates
6.12 Stealth BioTherapeutics
6.12.1 Stealth BioTherapeutics Corporation Information
6.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Stealth BioTherapeutics Product Portfolio
6.12.5 Stealth BioTherapeutics Recent Developments/Updates
6.13 Usher Syndrome
6.13.1 Usher Syndrome Corporation Information
6.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Usher Syndrome Product Portfolio
6.13.5 Usher Syndrome Recent Developments/Updates

7 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Cost Analysis
7.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
7.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
8.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers

9 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
9.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
9.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Growth Drivers
9.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
9.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints

10 Global Market Forecast
10.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2022-2027)
10.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2022-2027)
10.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Covered in This Study
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers (2016-2021)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Sites and Area Served
Table 11. Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2016-2021)
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2016-2021)
Table 20. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2016-2021)
Table 22. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2016-2021)
Table 24. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2016-2021)
Table 32. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2016-2021)
Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2016-2021)
Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2016-2021)
Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2016-2021)
Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2016-2021)
Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2016-2021)
Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2016-2021)
Table 45. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2016-2021)
Table 47. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2016-2021)
Table 48. Alkeus Pharmaceuticals Corporation Information
Table 49. Alkeus Pharmaceuticals Description and Business Overview
Table 50. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 51. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 52. Alkeus Pharmaceuticals Recent Developments/Updates
Table 53. Amgen Corporation Information
Table 54. Amgen Description and Business Overview
Table 55. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 56. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 57. Amgen Recent Developments/Updates
Table 58. Biovista Corporation Information
Table 59. Biovista Description and Business Overview
Table 60. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 61. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 62. Biovista Recent Developments/Updates
Table 63. Editas Medicine Corporation Information
Table 64. Editas Medicine Description and Business Overview
Table 65. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 66. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 67. Editas Medicine Recent Developments/Updates
Table 68. GenSight Biologics Corporation Information
Table 69. GenSight Biologics Description and Business Overview
Table 70. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 71. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 72. GenSight Biologics Recent Developments/Updates
Table 73. Ixchel Pharma Corporation Information
Table 74. Ixchel Pharma Description and Business Overview
Table 75. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 76. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 77. Ixchel Pharma Recent Developments/Updates
Table 78. Khondrion Corporation Information
Table 79. Khondrion Description and Business Overview
Table 80. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 81. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 82. Khondrion Recent Developments/Updates
Table 83. Mitotech Corporation Information
Table 84. Mitotech Description and Business Overview
Table 85. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 86. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 87. Mitotech Recent Developments/Updates
Table 88. ProQR Therapeutics Corporation Information
Table 89. ProQR Therapeutics Description and Business Overview
Table 90. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 91. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 92. ProQR Therapeutics Recent Developments/Updates
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Business Overview
Table 95. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 96. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 97. Sanofi Recent Developments/Updates
Table 98. Spark Therapeutics Corporation Information
Table 99. Spark Therapeutics Description and Business Overview
Table 100. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 101. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 102. Spark Therapeutics Recent Developments/Updates
Table 103. Stealth BioTherapeutics Corporation Information
Table 104. Stealth BioTherapeutics Description and Business Overview
Table 105. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 106. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 107. Stealth BioTherapeutics Recent Developments/Updates
Table 108. Usher Syndrome Corporation Information
Table 109. Usher Syndrome Description and Business Overview
Table 110. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 111. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 112. Usher Syndrome Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 116. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
Table 117. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 118. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Growth Drivers
Table 119. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 120. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Type (2022-2027) & (K Pcs)
Table 121. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Application (2022-2027) & (K Pcs)
Table 125. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2022-2027) & (K Pcs)
Table 129. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2020 & 2027
Figure 3. Dominant Optic Atrophy Product Picture
Figure 4. Recessive Optic Atrophy Product Picture
Figure 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Eye Clinics
Figure 8. Medical Research Institute
Figure 9. Other
Figure 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size 2016-2027 (US$ Million)
Figure 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2016-2027 (K Pcs)
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers in 2020
Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players: Market Share by Revenue in 2020
Figure 17. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2016-2021)
Figure 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region in 2020
Figure 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2016-2021)
Figure 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region in 2020
Figure 22. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2016-2021)
Figure 47. Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2016-2021)
Figure 48. Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application in 2020
Figure 49. Revenue Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2016-2021)
Figure 50. Revenue Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application in 2020
Figure 51. Manufacturing Cost Structure of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 52. Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 53. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed